338 related articles for article (PubMed ID: 9315417)
1. A phase I comparative study of contraceptive vaginal films containing benzalkonium chloride and nonoxynol-9. Postcoital testing and colposcopy.
Mauck CK; Baker JM; Barr SP; Abercrombie TJ; Archer DF
Contraception; 1997 Aug; 56(2):89-96. PubMed ID: 9315417
[TBL] [Abstract][Full Text] [Related]
2. A phase I comparative study of three contraceptive vaginal films containing nonoxynol-9. Postcoital testing and colposcopy.
Mauck CK; Baker JM; Barr SP; Johanson WM; Archer DF
Contraception; 1997 Aug; 56(2):97-102. PubMed ID: 9315418
[TBL] [Abstract][Full Text] [Related]
3. A phase I study of Femcap used with and without spermicide. Postcoital testing.
Mauck CK; Baker JM; Barr SP; Johanson W; Archer DF
Contraception; 1997 Aug; 56(2):111-5. PubMed ID: 9315420
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of the amount of nonoxynol-9 remaining in the vagina up to 4 h after insertion of a vaginal contraceptive film (VCF) containing 70 mg nonoxynol-9.
Mauck CK; Allen S; Baker JM; Barr SP; Abercrombie T; Archer DF
Contraception; 1997 Aug; 56(2):103-10. PubMed ID: 9315419
[TBL] [Abstract][Full Text] [Related]
5. Lea's Shield: a phase I postcoital study of a new contraceptive barrier device.
Archer DF; Mauck CK; Viniegra-Sibal A; Anderson FD
Contraception; 1995 Sep; 52(3):167-73. PubMed ID: 7587188
[TBL] [Abstract][Full Text] [Related]
6. Compatibility between the spermicide nonoxynol 9 and mid-cycle human cervical mucus.
Chantler E; Hemsworth M; Roach VP; Bruce JM
Contraception; 1992 Sep; 46(3):289-95. PubMed ID: 1333387
[TBL] [Abstract][Full Text] [Related]
7. Successful postcoital testing of Ovaprene: An investigational non-hormonal monthly vaginal contraceptive.
Mauck C; Thurman A; Jensen JT; Schreiber CA; Baker J; Hou MY; Chavoustie S; Dart C; Wu H; Zack N; Hatheway J; Friend D
Contraception; 2024 Apr; 132():110373. PubMed ID: 38232942
[TBL] [Abstract][Full Text] [Related]
8. A phase I randomized postcoital testing and safety study of the Caya diaphragm used with 3% Nonoxynol-9 gel, ContraGel or no gel.
Mauck CK; Brache V; Kimble T; Thurman A; Cochon L; Littlefield S; Linton K; Doncel GF; Schwartz JL
Contraception; 2017 Aug; 96(2):124-130. PubMed ID: 28606382
[TBL] [Abstract][Full Text] [Related]
9. Effects of multiple applications of benzalkonium chloride and nonoxynol 9 on the vaginal epithelium in the pigtailed macaque (Macaca nemestrina).
Patton DL; Kidder GG; Sweeney YC; Rabe LK; Hillier SL
Am J Obstet Gynecol; 1999 May; 180(5):1080-7. PubMed ID: 10329859
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of an optimized benzalkonium chloride gel as vaginal contraceptive: a randomized controlled trial among Chinese women.
Li W; Huang Z; Wu Y; Wang H; Zhou X; Xiao Z; Ding X; Xu J
Contraception; 2013 Jun; 87(6):756-65. PubMed ID: 23089047
[TBL] [Abstract][Full Text] [Related]
11. Alteration of human sperm kinematics in cervical mucus due to nonoxynol-9.
Dunmire EN; Katz DF
Contraception; 1997 Apr; 55(4):209-17. PubMed ID: 9179452
[TBL] [Abstract][Full Text] [Related]
12. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases.
Roddy RE; Zekeng L; Ryan KA; Tamoufé U; Weir SS; Wong EL
N Engl J Med; 1998 Aug; 339(8):504-10. PubMed ID: 9709043
[TBL] [Abstract][Full Text] [Related]
13. The postcoital test as a method of evaluating a contraceptive jelly.
Cohen MR; Kaye BM
J Am Med Assoc; 1953 Jul; 152(11):1042-3. PubMed ID: 12255243
[TBL] [Abstract][Full Text] [Related]
14. Spermicidal and antiviral properties of cholic acid: contraceptive efficacy of a new vaginal sponge (Protectaid) containing sodium cholate.
Psychoyos A; Creatsas G; Hassan E; Georgoulias V; Gravanis A
Hum Reprod; 1993 Jun; 8(6):866-9. PubMed ID: 7688380
[TBL] [Abstract][Full Text] [Related]
15. SILCS diaphragm: postcoital testing of a new single-size contraceptive device.
Schwartz JL; Ballagh SA; Creinin MD; Rountree RW; Kilbourne-Brook M; Mauck CK; Callahan MM
Contraception; 2008 Sep; 78(3):237-44. PubMed ID: 18692615
[TBL] [Abstract][Full Text] [Related]
16. The effects of frequent nonoxynol-9 use on the vaginal and cervical mucosa.
Niruthisard S; Roddy RE; Chutivongse S
Sex Transm Dis; 1991; 18(3):176-9. PubMed ID: 1658953
[TBL] [Abstract][Full Text] [Related]
17. Dose-response effects of gramicidin-D, EDTA, and nonoxynol-9 on sperm motion parameters and acrosome status.
Centola GM
Contraception; 1998 Jul; 58(1):35-8. PubMed ID: 9743894
[TBL] [Abstract][Full Text] [Related]
18. Postcoital testing after the use of a bio-adhesive acid buffering gel (ACIDFORM) and a 2% nonoxynol-9 product.
Amaral E; Perdigão A; Souza MH; Mauck C; Waller D; Zaneveld L; Faúndes A
Contraception; 2004 Dec; 70(6):492-7. PubMed ID: 15541412
[TBL] [Abstract][Full Text] [Related]
19. ZB-06, a vaginal film containing an engineered human contraceptive antibody (HC4-N), demonstrates safety and efficacy in a phase 1 postcoital test and safety study.
Thurman AR; Moench TR; Hoke M; Politch JA; Cabral H; Mausser E; Nador E; Morton J; Hamorsky K; Swope K; Bratcher B; Anderson DJ; Whaley KJ
Am J Obstet Gynecol; 2023 Jun; 228(6):716.e1-716.e12. PubMed ID: 36870409
[TBL] [Abstract][Full Text] [Related]
20. Study of the vaginal tolerance to Acidform, an acid-buffering, bioadhesive gel.
Amaral E; Faúndes A; Zaneveld L; Waller D; Garg S
Contraception; 1999 Dec; 60(6):361-6. PubMed ID: 10715372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]